Oncology & Cancer
Vaccine for HER2 breast cancer shows early promise
A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer.
Mar 12, 2019
0
752
News tagged with her2
Oncology & Cancer
Researchers uncover two-drug combo that halts the growth of cancer cells
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combo that halts the growth of cancer cells that carry HER2 mutations.
Jan 23, 2020
0
75
Oncology & Cancer
Spotting breast cancer's spread to the brain before symptoms start could improve survival
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.
Sep 18, 2020
0
9
Oncology & Cancer
Targeting 'Achilles' heel' could supercharge breast cancer treatment
A new class of anti-cancer agents that target cancer cells' 'Achilles' heel' could help to supercharge breast cancer treatment, improving outcomes for some of the most aggressive types of breast cancer.
Aug 2, 2017
0
166
Oncology & Cancer
New signaling pathway discovered in HER2-positive breast cancer, and two powerful drug targets
One of the most promising ideas in cancer treatment is to apply a lesson learned in the fight against AIDS (Acquired Immune Deficiency Syndrome): simultaneously attacking a pathological process at different points of weakness ...
Apr 20, 2015
0
30
Oncology & Cancer
T cell bispecific antibody for the immune-mediated killing of HER2+ breast cancer cells
Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Today however, novel immunotherapeutics across different tumor types, either ...
Oct 3, 2018
0
128
Oncology & Cancer
New therapy targets breast cancer metastases in brain
When breast cancer spreads to the brain, the prognosis is grim. Patients only have about six months to live.
Aug 26, 2020
0
210
Oncology & Cancer
Unexpected findings on weight loss and breast cancer from international study
New research in the February 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast cancer, and found a 5% weight loss in ...
Feb 16, 2021
0
7
Oncology & Cancer
Nanodrug targeting breast cancer cells from the inside adds weapon: Immune system attack
A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer ...
Aug 10, 2013
0
0
Oncology & Cancer
Significant discovery could tackle spread of breast cancer
(Medical Xpress)—For the first time, researchers from Queen Mary University of London (QMUL) have revealed the molecule αvβ6 (alpha v beta 6) plays a fundamental role in helping breast cancer cells to grow and spread. ...
Jul 4, 2014
0
0
HER2/neu
HER2/neu (also known as ErbB-2) stands for "Human Epidermal growth factor Receptor 2" and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2/neu has also been designated as CD340 (cluster of differentiation 340) and p185. It is encoded by the ERBB2 gene.
This text uses material from Wikipedia, licensed under CC BY-SA
